Replies to post #81097 on Biotech Values

[mouton29]

Re: Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX18

Any reactions? Was their reticence to express a view on whether Novartis would want to proceed normal caution or is it that the results are a little short of spectacular (as the aftermarket seems to have voted)?